Last week, the small end of town was where all the action was in biotech-land with Biotron (ASX:BIT) up 97%, newcomer Innate Therapeutics (ASX:IIL) up 33% and...

Matthijs Smith
Matthijs Smith
Canaccord Genuity Australia